Last reviewed · How we verify
Placebo Nasal Aerosol
Placebo Nasal Aerosol is a Small molecule drug developed by Teva Branded Pharmaceutical Products R&D, Inc.. It is currently in Phase 3 development.
A placebo nasal aerosol contains no active pharmaceutical ingredient and produces therapeutic effects through the placebo effect.
At a glance
| Generic name | Placebo Nasal Aerosol |
|---|---|
| Sponsor | Teva Branded Pharmaceutical Products R&D, Inc. |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Placebo formulations are inert preparations used as control comparators in clinical trials to assess the true efficacy of investigational drugs by accounting for patient expectation and natural disease progression. In a Phase 3 trial context, this nasal aerosol serves as the control arm to evaluate whether an active drug candidate demonstrates statistically significant benefit beyond placebo response.
Approved indications
Common side effects
Key clinical trials
- Vaccine Pandemic Preparedness Through Airway Immunology Characterization (EARLY_PHASE1)
- Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps (PHASE3)
- Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia (PHASE1, PHASE2)
- The Importance of Insulin Action in the Brain for the Immune System During Physical Activity-Overweight (NA)
- Combination Gerotherapeutic Interventions for Healthspan Improvement (PHASE3)
- A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults (PHASE1)
- Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD) (PHASE2)
- A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo Nasal Aerosol CI brief — competitive landscape report
- Placebo Nasal Aerosol updates RSS · CI watch RSS
- Teva Branded Pharmaceutical Products R&D, Inc. portfolio CI